Regional Report
$720.00 – $3,720.00
- EUR: €635.59 - €3,283.90
- INR: ₹51,409.00 - ₹265,613.19
- AED: د.إ2,642.40 - د.إ13,652.40
- GBP: £556.91 - £2,877.35
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Drug delivery describes the method and approach to delivering drugs or pharmaceuticals to their site of action within an organism. The main goal of drug delivery is to achieve a therapeutic outcome. The issues of pharmacodynamics and pharmacokinetics are the important considerations for drug delivery.
South America Drug Delivery Devices Market Report Segments Size & Growth:
South America drug delivery devices market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include technological advancements, increased prevalence of chronic diseases, need for controlled drug release, the rise in individual therapy, and increased understanding about drug metabolism among the population. However, recall of the products, strict regulatory framework, and injuries and infections fear while usage is thereby hindering the market growth. Various opportunities for drug delivery devices market include increasing demand for biosimilars and generic drugs, focus on overcoming unmet medical needs, self-administration & home care, and emerging markets.
South America Drug Delivery Devices Market Report Segments Share:
South America drug delivery devices market is categorised into the mode of delivery which comprises of nasal, oral, ocular, implantable, injectable, transdermal, topical, pulmonary, rectal, and other. Furthermore, they are categorised into various sub-segments. By nasal, it is segmented into nasal inhalers, nasal sprays, nasal drops, and others. By oral, it is segmented into hydrodynamic pressure controlled system, slow dissolving salts & complexes, ion – exchange resin drug complexes, Ph – independent formulations, osmotic pressure controlled systems, diffusion controlled systems, and dissolution controlled systems. By ocular, it is segmented into ointments & gels, eye drops, and others. By implantable, it is segmented into intravitreal implants, brachytherapy seeds, contraceptives, and drug-eluting stents. By injectable, it is segmented into conventional drug delivery and self-Injected drug delivery.
By transdermal, it is segmented into the mode of administration, type of patches, & transdermal gels and they are further segmented into microscopic injections, ultrasound, electroporation, iontophoresis, vapour patch, matrix, reservoir, multilayer drug in adhesive, single layer drug in the adhesive. By topical, it is segmented into semi-solid formulations, liquid formulations, and solid formulations. By pulmonary, it is segmented into the nebuliser, dry powder inhalers, and metered dose inhalers. The topical segment is anticipated to witness the highest growth rate. The factors which the boosting the growth of the segment are convenience and ease of use, ease of dosage, painlessness, noninvasiveness, and enhanced patient compliance.
By end-users, the market is segmented into hospitals, ambulatory surgical centres or clinics, home care settings, diagnostic centres, and others. Among them, the hospital’s segment is expected to hold the largest share in the market during the forecast period owing to increasing number of inpatient and outpatient visits in hospitals when compared to others and the requirement of large volumes of drugs and their respective delivery devices to procure to the demand of the patient pool.
By Geography, Brazil is expected to hold the largest share in the market because of the increasing demand for improved drug delivery systems, rising accessibility and affordability of drug delivery devices, and increasing number of chronic diseases in the region. Argentina is expected to witness the highest growth rate because of rising prevalence of various chronic diseases and ageing population in this region. Furthermore, the improving economic conditions in the region are also expected to support the growth of the drug delivery devices market in South-America.
South America Drug Delivery Devices Market Report Trends:
- Baxter International Inc., a global leader in sterile medication production and delivery, announced that the U.S. Food and Drug Administration approved the medication used in a common nonsurgical procedure to treat blocked or narrowed blood vessels in the heart.
- Smith medical company has launched a new product called CADD-solis VIP ambulatory infusion pump, reliable pump performance, accurate medication delivery and ease of use.
South America Drug Delivery Devices Market Report Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The major market players, such as
- Abbott Laboratories
- Braun Melsungen AG
- Pfizer, Inc.
- Hoffmann-La Roche Ltd.
- Baxter International Inc.
Along with these companies, there were many other companies considered/cited in the report while analysing the South America drug delivery devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Technological advancements
4.1.2 Increased prevalence of chronic diseases
4.1.3 Need for controlled drug release
4.1.4 Rise in individual therapy
4.1.5 Increased understanding about drug metabolism among the population
4.2 Restraints
4.2.1 Recall of the products
4.2.2 strict regulatory framework
4.2.3 Injuries and infections fear while usage
4.3 Opportunities
4.3.1 Increasing demand for biosimilars and generic drugs
4.3.2 Focus on overcoming unmet medical needs
4.3.3 Self-administration and home care
4.3.4 Emerging markets
4.4 Challenges
4.4.1 High cost of development
4.4.2 Patent cliff and patent expiry
Chapter 5 South America Drug Delivery Devices Market– By Mode of Delivery
5.1 Nasal
5.1.1 Nasal inhalers
5.1.2 Nasal sprays
5.1.3 Nasal drops
5.1.4 Others
5.2 Oral
5.2.1 By mode of action
5.2.1.1 Hydrodynamic pressure controlled system
5.2.1.2 Slow dissolving salts & complexes
5.2.1.3 Ion – exchange resin drug complexes
5.2.1.4 Ph – independent formulations
5.2.1.5 Osmotic pressure controlled systems
5.2.1.6 Diffusion controlled systems
5.2.1.7 Dissolution controlled systems
5.3 Ocular
5.3.1 Ointments & gels
5.3.2 Eye drops
5.3.3 Others
5.4 Implantable
5.4.1 Intravitreal implants
5.4.2 Brachytherapy seeds
5.4.3 Contraceptives
5.4.4 Drug-eluting stents
5.5 Injectable
5.5.1 Conventional drug delivery
5.5.2 Self-Injected drug delivery
5.5.2.1 Prefilled syringes
5.5.2.2 Injectable pen
5.5.2.3 Autoinjectors
5.5.2.4 Needle-free injectors
5.5.2.5 Self Flushing infusion bag
5.6 Transdermal
5.6.1 By mode of administration
5.6.1.1 Microscopic injections
5.6.1.2 Ultrasound
5.6.1.3 Electroporation
5.6.1.4 Iontophoresis
5.6.2 By type of patches
5.6.2.1 Vapour patch
5.6.2.2 Matrix
5.6.2.3 Reservoir
5.6.2.4 Multilayer drug in adhesive
5.6.2.5 Single layer drug in adhesive
5.6.3 Transdermal Gels
5.7 Topical
5.7.1 Semi-solid formulations
5.7.2 Liquid formulations
5.7.3 Solid formulations
5.8 Pulmonary
5.8.1 By mode of administration
5.8.1.1 Nebulizer
5.8.1.2 Dry powder inhalers
5.8.1.3 Metered dose inhalers
5.9 Rectal
5.10 Others
Chapter 6 South America Drug Delivery Devices Market- By End-Users
6.1 Hospitals
6.2 Ambulatory Surgical Centers/Clinics
6.3Home Care Settings
6.4 Diagnostic Centers
6.5 Others
Chapter 7 South America Drug Delivery Devices Market- By Geography
7.1 Introduction
7.2 Brazil
7.3 Argentina
7.4 Others
Chapter 8 South America Drug Delivery Devices Market- Company Profiles
8.1 Abbott Laboratories
8.2 B. Braun Melsungen AG
8.3 Pfizer, Inc.
8.4 F. Hoffmann-La Roche Ltd.
8.5 Baxter International Inc.
8.6 Smith Medical
8.7 3M Company
8.8 Johnson & Johnson Services, Inc.
8.9 Novartis AG
8.10 Sanofi Pharmaceutical company
8.11 Bayer AG
8.12 Merck & Co., Inc.
8.13 Becton, Dickinson and Company
8.14 GlaxoSmithKline PLC
Chapter 9 South America Drug Delivery Devices Market- Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Request Free Sample
Click below to request free sample of this report.
Why buy reports from Envision Inteligence
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition.
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues.
Best Price Guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices.
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance.
Drug delivery describes the method and approach to delivering drugs or pharmaceuticals to their site of action within an organism. The main goal of drug delivery is to achieve a therapeutic outcome. The issues of pharmacodynamics and pharmacokinetics are the important considerations for drug delivery.
South America Drug Delivery Devices Market Report Segments Size & Growth:
South America drug delivery devices market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include technological advancements, increased prevalence of chronic diseases, need for controlled drug release, the rise in individual therapy, and increased understanding about drug metabolism among the population. However, recall of the products, strict regulatory framework, and injuries and infections fear while usage is thereby hindering the market growth. Various opportunities for drug delivery devices market include increasing demand for biosimilars and generic drugs, focus on overcoming unmet medical needs, self-administration & home care, and emerging markets.
South America Drug Delivery Devices Market Report Segments Share:
South America drug delivery devices market is categorised into the mode of delivery which comprises of nasal, oral, ocular, implantable, injectable, transdermal, topical, pulmonary, rectal, and other. Furthermore, they are categorised into various sub-segments. By nasal, it is segmented into nasal inhalers, nasal sprays, nasal drops, and others. By oral, it is segmented into hydrodynamic pressure controlled system, slow dissolving salts & complexes, ion – exchange resin drug complexes, Ph – independent formulations, osmotic pressure controlled systems, diffusion controlled systems, and dissolution controlled systems. By ocular, it is segmented into ointments & gels, eye drops, and others. By implantable, it is segmented into intravitreal implants, brachytherapy seeds, contraceptives, and drug-eluting stents. By injectable, it is segmented into conventional drug delivery and self-Injected drug delivery.
By transdermal, it is segmented into the mode of administration, type of patches, & transdermal gels and they are further segmented into microscopic injections, ultrasound, electroporation, iontophoresis, vapour patch, matrix, reservoir, multilayer drug in adhesive, single layer drug in the adhesive. By topical, it is segmented into semi-solid formulations, liquid formulations, and solid formulations. By pulmonary, it is segmented into the nebuliser, dry powder inhalers, and metered dose inhalers. The topical segment is anticipated to witness the highest growth rate. The factors which the boosting the growth of the segment are convenience and ease of use, ease of dosage, painlessness, noninvasiveness, and enhanced patient compliance.
By end-users, the market is segmented into hospitals, ambulatory surgical centres or clinics, home care settings, diagnostic centres, and others. Among them, the hospital’s segment is expected to hold the largest share in the market during the forecast period owing to increasing number of inpatient and outpatient visits in hospitals when compared to others and the requirement of large volumes of drugs and their respective delivery devices to procure to the demand of the patient pool.
By Geography, Brazil is expected to hold the largest share in the market because of the increasing demand for improved drug delivery systems, rising accessibility and affordability of drug delivery devices, and increasing number of chronic diseases in the region. Argentina is expected to witness the highest growth rate because of rising prevalence of various chronic diseases and ageing population in this region. Furthermore, the improving economic conditions in the region are also expected to support the growth of the drug delivery devices market in South-America.
South America Drug Delivery Devices Market Report Trends:
- Baxter International Inc., a global leader in sterile medication production and delivery, announced that the U.S. Food and Drug Administration approved the medication used in a common nonsurgical procedure to treat blocked or narrowed blood vessels in the heart.
- Smith medical company has launched a new product called CADD-solis VIP ambulatory infusion pump, reliable pump performance, accurate medication delivery and ease of use.
South America Drug Delivery Devices Market Report Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The major market players, such as
- Abbott Laboratories
- Braun Melsungen AG
- Pfizer, Inc.
- Hoffmann-La Roche Ltd.
- Baxter International Inc.
Along with these companies, there were many other companies considered/cited in the report while analysing the South America drug delivery devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Technological advancements
4.1.2 Increased prevalence of chronic diseases
4.1.3 Need for controlled drug release
4.1.4 Rise in individual therapy
4.1.5 Increased understanding about drug metabolism among the population
4.2 Restraints
4.2.1 Recall of the products
4.2.2 strict regulatory framework
4.2.3 Injuries and infections fear while usage
4.3 Opportunities
4.3.1 Increasing demand for biosimilars and generic drugs
4.3.2 Focus on overcoming unmet medical needs
4.3.3 Self-administration and home care
4.3.4 Emerging markets
4.4 Challenges
4.4.1 High cost of development
4.4.2 Patent cliff and patent expiry
Chapter 5 South America Drug Delivery Devices Market– By Mode of Delivery
5.1 Nasal
5.1.1 Nasal inhalers
5.1.2 Nasal sprays
5.1.3 Nasal drops
5.1.4 Others
5.2 Oral
5.2.1 By mode of action
5.2.1.1 Hydrodynamic pressure controlled system
5.2.1.2 Slow dissolving salts & complexes
5.2.1.3 Ion – exchange resin drug complexes
5.2.1.4 Ph – independent formulations
5.2.1.5 Osmotic pressure controlled systems
5.2.1.6 Diffusion controlled systems
5.2.1.7 Dissolution controlled systems
5.3 Ocular
5.3.1 Ointments & gels
5.3.2 Eye drops
5.3.3 Others
5.4 Implantable
5.4.1 Intravitreal implants
5.4.2 Brachytherapy seeds
5.4.3 Contraceptives
5.4.4 Drug-eluting stents
5.5 Injectable
5.5.1 Conventional drug delivery
5.5.2 Self-Injected drug delivery
5.5.2.1 Prefilled syringes
5.5.2.2 Injectable pen
5.5.2.3 Autoinjectors
5.5.2.4 Needle-free injectors
5.5.2.5 Self Flushing infusion bag
5.6 Transdermal
5.6.1 By mode of administration
5.6.1.1 Microscopic injections
5.6.1.2 Ultrasound
5.6.1.3 Electroporation
5.6.1.4 Iontophoresis
5.6.2 By type of patches
5.6.2.1 Vapour patch
5.6.2.2 Matrix
5.6.2.3 Reservoir
5.6.2.4 Multilayer drug in adhesive
5.6.2.5 Single layer drug in adhesive
5.6.3 Transdermal Gels
5.7 Topical
5.7.1 Semi-solid formulations
5.7.2 Liquid formulations
5.7.3 Solid formulations
5.8 Pulmonary
5.8.1 By mode of administration
5.8.1.1 Nebulizer
5.8.1.2 Dry powder inhalers
5.8.1.3 Metered dose inhalers
5.9 Rectal
5.10 Others
Chapter 6 South America Drug Delivery Devices Market- By End-Users
6.1 Hospitals
6.2 Ambulatory Surgical Centers/Clinics
6.3Home Care Settings
6.4 Diagnostic Centers
6.5 Others
Chapter 7 South America Drug Delivery Devices Market- By Geography
7.1 Introduction
7.2 Brazil
7.3 Argentina
7.4 Others
Chapter 8 South America Drug Delivery Devices Market- Company Profiles
8.1 Abbott Laboratories
8.2 B. Braun Melsungen AG
8.3 Pfizer, Inc.
8.4 F. Hoffmann-La Roche Ltd.
8.5 Baxter International Inc.
8.6 Smith Medical
8.7 3M Company
8.8 Johnson & Johnson Services, Inc.
8.9 Novartis AG
8.10 Sanofi Pharmaceutical company
8.11 Bayer AG
8.12 Merck & Co., Inc.
8.13 Becton, Dickinson and Company
8.14 GlaxoSmithKline PLC
Chapter 9 South America Drug Delivery Devices Market- Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.